Homocysteine and thrombotic disease
A D'Angelo, J Selhub - Blood, The Journal of the American …, 1997 - ashpublications.org
PATHOGENESIS OF HYPERHOMOCYSTEINEMIA OMOCYSTEINE is a non–protein-forming,
sulfur amino acid whose metabolism is at the intersection of The more severe cases of …
sulfur amino acid whose metabolism is at the intersection of The more severe cases of …
Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT)
…, N Leali, S Coccheri, M Poggi, C Manotti, A D'Angelo… - The Lancet, 1996 - thelancet.com
Background Bleeding is the most serious complication of the use of oral anticoagulation in
the prevention and treatment of thromoboembolic complications. We studied the frequency of …
the prevention and treatment of thromoboembolic complications. We studied the frequency of …
Comparison between different D‐D imer cutoff values to assess the individual risk of recurrent venous thromboembolism: analysis of results obtained in the DULCIS …
…, AM Pizzini, L Angeloni, A D'angelo… - International Journal …, 2016 - Wiley Online Library
Introduction D‐dimer assay, generally evaluated according to cutoff points calibrated for VTE
exclusion, is used to estimate the individual risk of recurrence after a first idiopathic event of …
exclusion, is used to estimate the individual risk of recurrence after a first idiopathic event of …
[HTML][HTML] Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working …
…, G Landoni, A Ruggeri, J Peccatori, A D'Angelo… - Critical care and …, 2020 - Elsevier
We suggest the use of MicroCLOTS (microvascular COVID-19 lung vessels obstructive
thromboinflammatory syndrome) as a new name for severe pulmonary coronavirus disease 2019 …
thromboinflammatory syndrome) as a new name for severe pulmonary coronavirus disease 2019 …
Acquired deficiencies of protein S. Protein S activity during oral anticoagulation, in liver disease, and in disseminated intravascular coagulation.
A D'Angelo, S Vigano-D'Angelo… - The Journal of clinical …, 1988 - Am Soc Clin Investig
Protein S is a vitamin K-dependent plasma protein which serves as the cofactor for activated
protein C. Protein S circulates in both an active, free form and in an inactive complex with …
protein C. Protein S circulates in both an active, free form and in an inactive complex with …
Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery
…, P Severi, M Pini, A D'Angelo… - … England Journal of …, 1998 - Mass Medical Soc
Background Compression stockings are recommended for prophylaxis against venous
thromboembolism in patients undergoing neurosurgery, but anticoagulant agents have not …
thromboembolism in patients undergoing neurosurgery, but anticoagulant agents have not …
Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry
…, E Rossi, F Baudo, C Manotti, A D'Angelo… - The American journal of …, 1996 - Elsevier
PURPOSE: To assess the natural history and risk factors for thrombosis in a large cohort of
unselected patients with antiphospholipid antibodies. PATIENTS AND METHODS: Three …
unselected patients with antiphospholipid antibodies. PATIENTS AND METHODS: Three …
A microRNA-regulated lentiviral vector mediates stable correction of hemophilia B mice
…, A Lombardo, P Della Valle, A D'Angelo… - Blood, The Journal …, 2007 - ashpublications.org
A longstanding goal for the treatment of hemophilia B is the development of a gene transfer
strategy that can maintain sustained production of clotting factor IX (F.IX) in the absence of …
strategy that can maintain sustained production of clotting factor IX (F.IX) in the absence of …
Prevalence of moderate hyperhomocysteinemia in patients with early-onset venous and arterial occlusive disease
I Fermo, SV D'Angelo, R Paroni, G Mazzola… - Annals of internal …, 1995 - acpjournals.org
Objective: To evaluate the prevalence of moderate hyperhomocysteinemia and inherited
thrombophilia disorders (congenital defects of the natural anticoagulant or fibrinolytic …
thrombophilia disorders (congenital defects of the natural anticoagulant or fibrinolytic …
A comparison of the safety and efficacy of oral antiocoagulation for the treatment of venous thromboembolic disease in patients with or without malignancy
…, A Lee, C Manotti, J Hirsh, A D'Angelo… - Thrombosis and …, 2000 - thieme-connect.com
The optimal long-term treatment of acute venous thromboembolism (VTE) in patients with
malignancy remains undefined. In particular, based on current evidence, it is uncertain …
malignancy remains undefined. In particular, based on current evidence, it is uncertain …
